A novel antifolate suppresses growth of FPGS-deficient cells and overcomes methotrexate resistance

Cancer cells make extensive use of the folate cycle to sustain increased anabolic metabolism. Multiple chemotherapeutic drugs interfere with the folate cycle, including methotrexate and 5-fluorouracil that are commonly applied for the treatment of leukemia and colorectal cancer (CRC), respectively....

Descripción completa

Detalles Bibliográficos
Autores principales: van der Krift, Felix, Zijlmans, Dick W, Shukla, Rhythm, Javed, Ali, Koukos, Panagiotis I, Schwarz, Laura LE, Timmermans-Sprang, Elpetra PM, Maas, Peter EM, Gahtory, Digvijay, van den Nieuwboer, Maurits, Mol, Jan A, Strous, Ger J, Bonvin, Alexandre MJJ, van der Stelt, Mario, Veldhuizen, Edwin JA, Weingarth, Markus, Vermeulen, Michiel, Klumperman, Judith, Maurice, Madelon M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435995/
https://www.ncbi.nlm.nih.gov/pubmed/37591722
http://dx.doi.org/10.26508/lsa.202302058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435995/
https://www.ncbi.nlm.nih.gov/pubmed/37591722
http://dx.doi.org/10.26508/lsa.202302058

Ejemplares similares